-

Allscripts Announces ADP Empower to Help Amplify Diverse Voices in the Healthcare Technology Industry

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) today announced its team that leads the Allscripts Developer Program (ADP) has launched ADP Empower, a new program designed to amplify diverse voices in the healthcare technology industry and offer valuable resources to underrepresented entrepreneurs to grow their businesses and accelerate innovation.

The Allscripts Developer Program helps build a culture of innovation by reducing barriers and risk associated with installing and using innovative healthcare technology. The company partners with developers to help deliver the tools they need to connect their innovation to Allscripts’ clients and achieve desired outcomes. Through ADP Empower, Allscripts will create a community of innovators that represents the perspectives, cultures and needs of its clients and their patients.

This initiative includes an empowerment package at no additional cost to minority-owned or led healthcare technology companies. This package includes an official Allscripts partnership, one-on-one guidance for technical, marketing and business development best practices, and client-facing opportunities to support lead generation. The goal is to provide Allscripts’ leadership, expertise, resources, technology, and support to underrepresented entrepreneurs, as well as facilitate a diverse community for fellowship and mentorship.

“Allscripts is determined to do our part to support diversity, equity and inclusion—both within Allscripts and beyond our walls,” said Allscripts Chief Executive Officer Paul Black. “As an extension of all the work we are doing inside Allscripts to nurture a workplace of DE&I, ADP Empower will help underrepresented entrepreneurs by supporting new technology, engaging with a diverse community, educating to fuel innovation and deploying integrated solutions to patients and providers.”

Allscripts is currently accepting applications for the upcoming ADP Empower cohort through May 28, 2021. The cohort will be announced in June, along with the ADP Empower kick-off event. Learn more at www.allscripts.com/ADPEmpower.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2021 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed. Mr. Greyenbuhl is a seasoned operator and finance executive with more than 25 years o...

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...
Back to Newsroom